Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells - Gong, Baocheng; Zhang, Jinhua; Hua, Zhongyan; Liu, Zhihui; Thiele, Carol J.; Li, Zhijie (Frontiers in Oncology, 2022)